Aharon Schwartz serves as Executive at Foamix Pharmaceuticals Ltd., where they oversee executive responsibilities. Since joining the company, Aharon Schwartz has executed 8 insider transactions totaling $956.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 3, 2025 involved receiving (via award) 7,500 shares valued at $0.
Aharon Schwartz currently holds 7,500 shares of Foamix Pharmaceuticals Ltd. (FOMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aharon Schwartz has been a net buyer of FOMX stock. They have purchased $956.0K and sold $0 worth of shares.
Aharon Schwartz's most recent insider trade was on Sep 3, 2025, when they sold 7,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.60 |
| Discretionary |
| Jan 3, 2023 | PLX | $156.2K | Purchase | 110,000 | $1.42 | Discretionary |
| Apr 7, 2020 | PLX | $155.5K | Purchase | 64,000 | $2.43 | Discretionary |
| Mar 9, 2020 | FOMX | $0 | Disposition | 112,200 | $N/A | Discretionary |
| Nov 28, 2018 | FOMX | $47.3K | Purchase | 12,200 | $3.88 | Discretionary |
| Nov 27, 2018 | FOMX | $196.0K | Purchase | 50,000 | $3.92 | Discretionary |
| Nov 26, 2018 | FOMX | $194.5K | Purchase | 50,000 | $3.89 | Discretionary |